「planning」の検索結果

Assesses organizational readiness for post-quantum cryptography migration per NIST FIPS 203/204/205 standards. Performs cryptographic inventory scanning to identify quantum-vulnerable algorithms (RSA, ECDH, ECDSA), evaluates hybrid TLS configurations with X25519MLKEM768, and validates CRYSTALS-Kyber (ML-KEM) and CRYSTALS-Dilithium (ML-DSA) readiness. Implements crypto-agility assessment using oqs-provider for OpenSSL. Use planning yaparken or executing the transition from classical to post-quantu...

日本語の概要は準備中です。原文の説明を表示しています。

Busabase-backed project-based PPT production App-in-Skill. Use when the user invokes $kelly-ppt-factory or /kelly-ppt-factory, mentions PPT factory, 规模化 PPT, bulk PPTX, batch decks, reusable PowerPoint style systems, presentation production workflows, pitch decks, sales decks, training decks, report decks, slide-card/storyboard planning, style-consistent deck generation, PPTX QA, or wants to manage many PPTX files through project to deck to slide card to review to generate to render QA.

日本語の概要は準備中です。原文の説明を表示しています。

End-to-end ABM program design and orchestration for B2B SaaS mid-market and enterprise motions. Use when building a target account list, designing account tiering criteria, planning ABM channel orchestration, coordinating BDR outreach with marketing campaigns, defining ABM measurement frameworks, or running an ABM program review. Also use when asked to "build an ABM program," "set up account-based marketing," "design a target account strategy," "plan ABM campaigns," or "measure ABM results." Designed for demand gen teams selling to Mid-Market companies with $10K-$50K+ ACV, multi-persona buying committees, and 3-6 month sales cycles.

日本語の概要は準備中です。原文の説明を表示しています。

MUST USE when the user provides a photo ZIP, photo folder, or still-image event material and asks for photo selection, album selection, highlights, digest photos, curation, or quality filtering. Use this instead of analyze-footage when the source is primarily still photos and the requested work is selecting images rather than editing or video planning.

日本語の概要は準備中です。原文の説明を表示しています。

Manual-only orchestrator for medium-to-large software development. Turns a broad goal into PR-sized and operational nodes with verification gates, then coordinates approved execution across follow-up prompts. Activate only when the user explicitly invokes my-epic; once activated, keep orchestrating that epic for the rest of the session. Do NOT use for an uninvoked planning or implementation request, a single small bug fix, one obvious PR, pure code review, ordinary SDD work that fits in one spec/PR, or implementing an epic during the same first call that created it.

日本語の概要は準備中です。原文の説明を表示しています。

Builds a structured ransomware incident response playbook aligned with the CISA StopRansomware Guide and NIST Cybersecurity Framework. Covers preparation, detection, containment, eradication, recovery, and post-incident phases with actionable checklists. Activates for requests involving ransomware response planning, CISA compliance, incident response playbook creation, or ransomware preparedness assessment.

日本語の概要は準備中です。原文の説明を表示しています。

Database migrations, schema evolution, data transformation, and zero-downtime deployments. Use when creating migrations, evolving database schema, transforming data, or planning deployment strategies.

日本語の概要は準備中です。原文の説明を表示しています。

Plan a user interview topic in PostHog — pick who to target (cohort, emails, or PostHog distinct IDs), draft what to ask about, and prepare the voice-agent context plus a question list. Use when the user asks to "talk to users", "check how users feel about X", "interview some customers", "set up a user interview", "run a user-research call", "find users to ask about Y", or otherwise wants qualitative feedback through a conversation. Walks the user through targeting (cohorts-list, persons-list, or accepting emails / distinct IDs directly), captures the topic, and prompts for agent context and questions before calling user-interview-topics-create. Cohort targeting is resolved to explicit emails/distinct_ids at create time — topics snapshot their audience and do not re-evaluate cohort membership later. Do NOT trigger when the user is uploading a recorded interview audio file (that's the separate UserInterview/transcript flow) or only browsing existing topics with user-interview-topics-list.

日本語の概要は準備中です。原文の説明を表示しています。

Creative research ideation and exploration. Use for open-ended brainstorming sessions, exploring interdisciplinary connections, challenging assumptions, or identifying research gaps. Best for early-stage research planning when you do not have specific observations yet. For formulating testable hypotheses from data use hypothesis-generation.

日本語の概要は準備中です。原文の説明を表示しています。

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

日本語の概要は準備中です。原文の説明を表示しています。

Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.

日本語の概要は準備中です。原文の説明を表示しています。

Structures biological experiments so inference is valid by construction, covering Fisher's principles (randomization, replication, local control), the experimental-vs-observational unit distinction and pseudoreplication (Hurlbert 1984; Lazic 2018), randomization mechanics (complete, restricted, stratified, rerandomization, run-order), blocking layouts (randomized complete block, Latin square, incomplete block), factorial designs and interactions, and the split-plot/nested error strata hidden inside multi-batch genomics. Use when deciding the experimental unit and what counts as a replicate, planning randomization and run order, choosing a blocked/factorial/split-plot/nested layout, avoiding pseudoreplication in cell-culture or animal studies, or specifying the random-effects structure of the analysis model. For assigning samples to sequencing batches/lanes/plates and batch-effect correction see experimental-design/batch-design; for regulated clinical-trial randomization see clinical-biostatistics.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Validates predictive models on omics and biomedical data with nested cross-validation, group/batch/temporal-aware splits, the full data-leakage taxonomy, probability calibration, decision-curve net benefit, optimism correction, sample-size planning, and TRIPOD+AI reporting. Use when estimating model performance honestly, choosing a CV scheme, detecting leakage, or judging whether reported discrimination means the model is actually useful. For feature selection itself see machine-learning/biomarker-discovery; for confirmatory-trial inference see clinical-biostatistics/trial-reporting.

日本語の概要は準備中です。原文の説明を表示しています。

Find commercial sources for chemical compounds — PubChem/ChEMBL identity resolution then vendor catalog search across ZINC, Enamine, eMolecules, Mcule. Compares pricing, availability, and identifies purchasable analogs when an exact compound is not in stock. Use for chemical procurement, virtual library curation, and 'where can I buy X' questions for synthesis planning.

日本語の概要は準備中です。原文の説明を表示しています。

Designs PROTACs, molecular glues, and bivalent degraders with explicit handling of E3 ligase choice (VHL, CRBN, IAP, MDM2, KEAP1), linker design (length, composition, rigidity), ternary complex prediction (PRosettaC, DeepTernary, AlphaFold3 with constraints), cooperativity (alpha), DC50 / Dmax characterization, hook effect, and prediction-experiment reconciliation. Use when designing targeted protein degraders, planning linker SAR, predicting ternary complex stability, or building generative degrader workflows.

日本語の概要は準備中です。原文の説明を表示しています。

Analyzes chemical libraries by scaffold using Bemis-Murcko scaffolds, generic frameworks, cyclic skeletons, matched molecular pair (MMP) analysis via mmpdb, R-group decomposition, Free-Wilson analysis, scaffold hopping, and chemotype-aware ML train/test splits. Use when identifying chemotype clusters in a library, deriving SAR transformation rules, decomposing series into R-groups, performing scaffold-balanced QSAR splits, or planning analog campaigns.

日本語の概要は準備中です。原文の説明を表示しています。

PM planning workflow — analyze requirements, select tech stack, decompose into prioritized tasks with dependencies, and define API contracts

日本語の概要は準備中です。原文の説明を表示しています。

Design-first ideation workflow — explore user intent, clarify constraints, propose approaches, and produce an approved design document before planning

日本語の概要は準備中です。原文の説明を表示しています。

Turn product requirements into scoped tasks with dependencies and acceptance criteria. Use for implementation planning and prioritization.

日本語の概要は準備中です。原文の説明を表示しています。

Coordinate multiple agents for a complex multi-domain project using PM planning, parallel agent spawning, and QA review

日本語の概要は準備中です。原文の説明を表示しています。

When the user wants to plan a content strategy, decide what content to create, or figure out what topics to cover. Also use when the user mentions "content strategy," "what should I write about," "content ideas," "blog strategy," "topic clusters," or "content planning." For writing individual pieces, see copywriting. For SEO-specific audits, see seo-audit.

日本語の概要は準備中です。原文の説明を表示しています。

Answer Engine Optimization (AEO) skill — optimize content to be cited by AI language models (ChatGPT, Perplexity, Claude, Gemini, Mistral) as authoritative sources. Distinct from SEO — AEO optimizes for citation in LLM-generated responses, not search rankings. Use when planning content for AI-first search audiences, auditing existing content for E-E-A-T signals, tracking which pages get cited by which LLMs, or building a citation-friendly content strategy. Triggers — 'AEO audit', 'optimize for ChatGPT', 'get cited by Perplexity', 'LLM citation strategy', 'answer engine optimization', 'content for AI search', 'E-E-A-T audit'. Output is a markdown audit report (default) or JSON for pipeline integration. Stdlib-only Python tools.

日本語の概要は準備中です。原文の説明を表示しています。

Expert chaos engineer specializing in controlled failure injection, resilience testing, and building antifragile systems. Masters chaos experiments, game day planning, and continuous resilience improvement with focus on learning from failure.

日本語の概要は準備中です。原文の説明を表示しています。